Fake medicine billing allegations in Lucknow highlight gaps in pharmaceutical distribution, invoice verification, and drug traceability.
Bajaj Healthcare Q2 Results for FY27 show strong growth in revenue and profitability, supported by rising API exports and formulations sales.
India’s pharmaceutical sector is seeing major developments in drug pricing, cancer treatment, manufacturing, and international market expansion. The Centre has notified a 30 percent trade-margin cap on 137 anti-cancer drugs, while Lupin has...
Neovii Biotech and VINS Bioproducts plan immunoglobulin collaboration with technology transfer to India, potentially strengthening domestic biologics manufacturing and transplant care.
Eli Lilly's Foundayo pill gains EU regulatory backing, highlighting its flexible dosing without food or water restrictions.
.jpeg "Can India's Drug Discovery Push Help Startups Bridge R&D Funding Gap?")
India’s Rs 50 crore drug discovery funding under the PRIP scheme targets startups and MSMEs developing indigenous medicines. Applications close on 10 November 2026.
Mankind Pharma's Rs 511 crore investment in Armed Cell Therapeutics targets next-generation CAR-T therapies for difficult-to-treat cancers.
India pharma news: Mankind Pharma’s ?511 crore ACTx deal, Dr Reddy’s US FDA observations, Aurobindo’s ADQUEY launch and Novo Nordisk’s sickle cell initiative.
Novo Nordisk’s 35 percent growth hormone drug price cut in India puts treatment affordability and access in focus.
AstraZeneca pays USD 40 million for AI drug targets, partnering with insitro to advance discovery for liver and heart diseases.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
